NurExone Biologic Inc. — Form D

NurExone Biologic Inc. of TECHNION CITY, HAIFA, L3, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-25. The offering totals $430K, of which $430K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (15)

NameRoleLocation
James RichardsonDirectorConcord, MA
James RichardsonRelated PersonConcord, MA
Yoram DruckerDirectorTechnion City, Haifa, L3
Yoram DruckerExecutive OfficerTechnion City, Haifa, L3
Yoram DruckerRelated PersonTechnion City, Haifa, L3
Gadi RiesenfeldDirectorTechnion City, Haifa, L3
Oded OrgilDirectorTechnion City, Haifa, L3
Oded OrgilRelated PersonTechnion City, Haifa, L3
Eran OvadyaExecutive OfficerTechnion City, Haifa, L3
Eran OvadyaRelated PersonTechnion City, Haifa, L3
Lior ShaltielDirectorTechnion City, Haifa, L3
Lior ShaltielExecutive OfficerTechnion City, Haifa, L3
Lior ShaltielRelated PersonTechnion City, Haifa, L3
Eyal GabbaiDirectorTechnion City, Haifa, L3
Eyal GabbaiRelated PersonTechnion City, Haifa, L3

Other filings by this issuer (9)

FiledFormOfferingSold
2026-07-02D$442K$442K
2026-03-18D$280K$280K
2025-08-27D$243K$148K
2025-04-22D$3.8M$1.6M
2025-01-22D$435K$435K
2024-03-25D$43K$43K
2024-03-25D$1.0M$1.0M
2024-01-09D$2.5M$1.1M
2023-10-02D$742K$742K

More